Terms: = Sarcomas AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Prognosis
11 results:
1. Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma.
Du M; Gu J; Liu C; Liu N; Yu Z; Zhou C; Heng W; Cao Z; Wei F; Zhu K; Wang Y; Zhang W; Xue X; Zhang Y; Qian J
J Exp Clin Cancer Res; 2022 Apr; 41(1):154. PubMed ID: 35459258
[TBL] [Abstract] [Full Text] [Related]
2. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
[TBL] [Abstract] [Full Text] [Related]
3. Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma.
Kowalczyk JT; Wan X; Hernandez ER; Luo R; Lyons GC; Wilson KM; Gallardo DC; Isanogle KA; Robinson CM; Mendoza A; Heske CM; Chen JQ; Luo X; Kelly AE; Difilippantinio S; Robey RW; Thomas CJ; Sackett DL; Morrison DK; Randazzo PA; Jenkins LMM; Yohe ME
Mol Cancer Ther; 2021 Feb; 20(2):307-319. PubMed ID: 33158997
[TBL] [Abstract] [Full Text] [Related]
4. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency.
Han M; Napier CE; Frölich S; Teber E; Wong T; Noble JR; Choi EHY; Everett RD; Cesare AJ; Reddel RR
J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745338
[TBL] [Abstract] [Full Text] [Related]
5. Whole-exome sequencing identifies a somatic missense mutation of nbn in clear cell sarcoma of the salivary gland.
Zhang L; Jia Z; Mao F; Shi Y; Bu RF; Zhang B
Oncol Rep; 2016 Jun; 35(6):3349-56. PubMed ID: 27109316
[TBL] [Abstract] [Full Text] [Related]
6. HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas.
Ernst A; Anders H; Kapfhammer H; Orth M; Hennel R; Seidl K; Winssinger N; Belka C; Unkel S; Lauber K
Cancer Lett; 2015 Sep; 365(2):211-22. PubMed ID: 26044951
[TBL] [Abstract] [Full Text] [Related]
7. A new relative tumor sizing method in epi-metaphyseal osteosarcoma.
Kim SH; Shin KH; Park EH; Cho YJ; Park BK; Suh JS; Yang WI
BMC Cancer; 2015 Apr; 15():284. PubMed ID: 25885468
[TBL] [Abstract] [Full Text] [Related]
8. Useful markers for detecting minimal residual disease in cases of neuroblastoma.
Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Jun; 31(6):1071-4. PubMed ID: 18520032
[TBL] [Abstract] [Full Text] [Related]
9. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.
Adachi Y; Reynolds PN; Yamamoto M; Wang M; Takayama K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2001 Nov; 61(21):7882-8. PubMed ID: 11691808
[TBL] [Abstract] [Full Text] [Related]
10. Tumor size and prognosis in aggressively treated osteosarcoma.
Bieling P; Rehan N; Winkler P; Helmke K; Maas R; Fuchs N; Bielack S; Heise U; Jurgens H; Treuner J; Romanowski R; Exner U; Kotz R; Winkler K
J Clin Oncol; 1996 Mar; 14(3):848-58. PubMed ID: 8622033
[TBL] [Abstract] [Full Text] [Related]
11. [The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy].
Rehan N; Bieling P; Winkler P; Helmke K; Maas R; Baldini N; Heise U; Fuchs N; Winkler K
Klin Padiatr; 1993; 205(4):200-9. PubMed ID: 8377444
[TBL] [Abstract] [Full Text] [Related]
